Lee & Ko and Morgan Lewis to host a joint seminar on recent issues in pharmaceutical and bio-pharma industry

On September 19, Lee & Ko will host a joint seminar with Morgan Lewis, a U.S. law firm, targeting pharmaceutical and bio-pharma industry professionals. The seminar will be held at the Korea Pharmaceutical and Bio-Pharma Manufacturers Association’s main auditorium, and will address a wide range of recent issues in the pharmaceutical bio-industry, from IP case law trends in Korea to AI patent strategies in the medical field.

Lee & Ko’s attorneys Yu Seok Kim and Hong Seon Kim will present on the topic of “recent pharma-related IP case law trend in Korea,” “attracting investors and making equity investment in bio-startups” and “the latest issue in employee invention in pharmaceutical bio-industry.”

From Morgan Lewis, Dr. Hywel Jones, founder and CEO of Singular Bio, will share his real-life experience and know-how on growing and selling startups and present on the topic of “bio-startup growth and investment/sale strategies.” Following Dr. Jones’ presentation, Dr. Hye Seung Lee and attorney Ho Sang Lee will present on the topic of “bio/pharmaceutical U.S. patent strategy and drafting specifications” and “AI patent and patent strategy.”

According to Ms. Keum Nang Park, the Head of Lee & Ko’s Healthcare Group, “this joint seminar is meaningful because it covers a wide range of recent issues that needs to be discussed in the pharmaceutical bio-industry” and “will be an informative seminar for many pharmaceutical bio-industry professionals.”